OncoImmunology · 2018 · 37 citations · 35 references
MedicineImmunologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionCancer Stem CellsCytokine BiologyCytokines In Tumor ImmunityNotch SignalingCd4 Positive T CellsCytokine Signaling In CancerInflammation-driven ProgressionInterleukin-17 PathwayNotch Signaling ActivationT Helper 17 ImmunityTh17 Cell DifferentiationTh17 Effector Function
cells (Th17 cells) in NSCLC. IL-17░A enhanced the migration, invasion and stemness of NSCLC via STAT3/NF-κB/Notch1 signaling. Blockade of this signaling inhibited the migration, invasion and stemness of NSCLC mediated by IL-17░A. Th17 cells in NSCLC were closely associated with poor prognosis of NSCLC patients. Our results indicated that Th17 cell-derived IL-17░A plays an important role in tumor progression of NSCLC via STAT3/NF-κB/Notch1 signaling. Therefore, therapeutic strategies against this pathway would be valuable to be developed for NSCLC treatment.
35
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Xuexian O. Yang, Bhanu P. Pappu, Roza Nurieva et al. · Immunity · 2008 · 1.6K citations · Full text
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Sergei I. Grivennikov, Kepeng Wang, Daniel Mucida et al. · Nature · 2012 · 1.3K citations · Full text
Medicine, Immunology, Oncology +12
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Lin Wang, Tangsheng Yi, Marcin Kortylewski et al. · The Journal of Experimental Medicine · 2009 · 832 citations · Full text
Medicine, Immunology, Oncology +17